Cost-effectiveness of a mindfulness-based mental health promotion program: economic evaluation of a nonrandomized controlled trial with propensity score matching.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Mindfulness*; Health Promotion/*economics ; Mental Disorders/*prevention & control; Adult ; Cost-Benefit Analysis ; Female ; Germany ; Health Promotion/methods ; Humans ; Male ; Middle Aged ; Propensity Score
    • Abstract:
      Background: Mental health promotion programs have been shown to reduce the burden associated with mental distress and prevent the onset of mental disorders, but evidence of cost-effectiveness is scarce.
      Objective: To evaluate the cost-effectiveness of a mindfulness-based mental health prevention program provided by health coaches in a multi-site field setting in Germany.
      Methods: The single-study based economic evaluation was conducted as part of a nonrandomized controlled trial, comparing the effects of a group-based prevention program to usual care based on propensity score matching. Participants (N = 1166) were recruited via a large statutory health insurance fund. Health outcome was assessed with the Hospital Anxiety and Depression Scale (HADS). Cost outcomes were actually incurred costs compiled from the health insurance' records. Incremental cost-effectiveness ratios (ICER) were analyzed from a societal and a health care perspective for a 12-month time horizon with sampling uncertainty being handled using nonparametric bootstrapping. A cost-effectiveness acceptability curve was graphed to determine the probability of cost-effectiveness at different willingness-to-pay ceiling ratios.
      Results: From a societal perspective, prevention was cost-effective compared to usual-care by providing larger effects of 1.97 units on the HADS (95% CI [1.14, 2.81], p < 0.001) at lower mean incremental total costs of €-57 (95% CI [- 634, 480], p = 0.84), yielding an ICER of €-29 (savings) per unit improvement. From a health care perspective, the incremental health benefits were achieved at additional direct costs of €181 for prevention participants (95% CI [40, 318], p = 0.01) with an ICER of €91 per unit improvement on the HADS. Willingness-to-pay for the prevention program to achieve a 95% probability of being cost-effective compared to usual-care, was estimated at €225 per unit improvement on the HADS score from a societal, and €191 from a health care perspective respectively. Sensitivity analyses suggested differential cost-effect-ratios depending on the initial distress of participants.
      Limitations: Due to the complexity of the field trial, it was not feasible to randomize participants and offer an active control condition. This limitation was met by applying a rigorous matching procedure.
      Conclusions: Our results indicate that universal mental health promotion programs in community settings might be a cost-effective strategy to enhance well-being. Differences between the societal and health care perspective underline the call for joint funding in the dissemination of preventive services.
      Trial Registration: German Clinical Trials Registration ID: DRKS00006216 (2014/06/11, retrospective registration).
    • References:
      Biostatistics. 2002 Dec;3(4):459-75. (PMID: 12933592)
      Pharm Stat. 2011 Mar-Apr;10(2):150-61. (PMID: 20925139)
      Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188. (PMID: 24857402)
      Psychother Psychosom. 2016;85(6):375-377. (PMID: 27744437)
      BMC Med. 2018 Feb 23;16(1):28. (PMID: 29471877)
      Ann Surg. 2014 Jan;259(1):18-25. (PMID: 24096758)
      Br J Clin Psychol. 2014 Mar;53(1):1-5. (PMID: 24588759)
      Psychol Med. 2014 May;44(7):1381-90. (PMID: 23947797)
      N Engl J Med. 2017 Oct 5;377(14):1391-1398. (PMID: 28976864)
      Bull World Health Organ. 2014 Sep 1;92(9):672-9. (PMID: 25378758)
      Early Interv Psychiatry. 2015 Apr;9(2):85-92. (PMID: 24962626)
      Annu Rev Clin Psychol. 2011;7:169-201. (PMID: 21443447)
      Br J Psychiatry. 2014;204:249-51. (PMID: 24692749)
      Psychol Health. 2015 Jan;30(1):52-71. (PMID: 25141273)
      Med Care Res Rev. 2006 Apr;63(2):217-35. (PMID: 16595412)
      J Med Internet Res. 2017 Jan 04;19(1):e5. (PMID: 28052841)
      Eur Heart J. 2012 Aug;33(15):1893-901. (PMID: 22711757)
      JAMA. 2012 Mar 14;307(10):1033-4. (PMID: 22416097)
      J Anesth. 2016 Aug;30(4):553-61. (PMID: 27002511)
      Early Interv Psychiatry. 2015 Apr;9(2):93-9. (PMID: 24698212)
      Prev Sci. 2011 Dec;12(4):361-71. (PMID: 21732121)
      Clin Psychol Rev. 2017 Feb;51:30-47. (PMID: 27821267)
      Am J Psychiatry. 2008 Oct;165(10):1272-80. (PMID: 18765483)
      Health Aff (Millwood). 2016 Jun 1;35(6):1130-5. (PMID: 27193027)
      J Psychosom Res. 2002 Feb;52(2):69-77. (PMID: 11832252)
      Psychol Health. 2015 Jan;30(1):122-34. (PMID: 25109224)
      BMC Public Health. 2015 Aug 01;15:740. (PMID: 26231662)
      Health Promot Int. 2019 Jun 1;34(3):532-540. (PMID: 29509890)
      J Adolesc. 2015 Dec;45:127-37. (PMID: 26433734)
      BMC Med. 2014 May 09;12:74. (PMID: 24886246)
      Ind Health. 2018 Apr 7;56(2):160-165. (PMID: 29109358)
      Aust N Z J Psychiatry. 2011 Jan;45(1):36-44. (PMID: 21073354)
      Br J Psychiatry. 2014 Sep;205(3):236-43. (PMID: 24855127)
      Lancet Psychiatry. 2015 Nov;2(11):1036-42. (PMID: 26404415)
      Psychother Psychosom. 2015;84(1):30-6. (PMID: 25547522)
      Behav Res Ther. 2014 Dec;63:43-54. (PMID: 25282626)
      J Clin Epidemiol. 2014 Aug;67(8):932-9. (PMID: 24774469)
      PLoS One. 2011;6(8):e22884. (PMID: 21853053)
      Behav Res Ther. 2006 Jan;44(1):1-25. (PMID: 16300724)
      Eur J Neurol. 2012 Jan;19(1):155-62. (PMID: 22175760)
      Br J Psychiatry. 2010 Apr;196(4):319-25. (PMID: 20357310)
      Br J Psychiatry. 2014 Nov;205(5):390-7. (PMID: 25257063)
      Multivariate Behav Res. 2011 May;46(3):399-424. (PMID: 21818162)
      Value Health. 2013 Mar-Apr;16(2):231-50. (PMID: 23538175)
      Cochrane Database Syst Rev. 2013 Nov 19;(11):CD009149. (PMID: 24249541)
      Health Aff (Millwood). 2010 Feb;29(2):304-11. (PMID: 20075081)
      J Psychosom Res. 2010 Oct;69(4):371-8. (PMID: 20846538)
      Scand J Work Environ Health. 2018 Mar 1;44(2):171-182. (PMID: 29144535)
      Health Qual Life Outcomes. 2003 Aug 01;1:29. (PMID: 12914662)
      Br J Psychiatry. 2010 Nov;197(5):348-9. (PMID: 21037210)
      Qual Life Res. 1997 Mar;6(2):159-68. (PMID: 9161116)
      Behav Cogn Psychother. 2018 Jan;46(1):101-114. (PMID: 28903792)
      Gesundheitswesen. 2009 Jan;71(1):19-23. (PMID: 19173145)
      Psychol Med. 2016 Jan;46(1):11-26. (PMID: 26315536)
      Value Health. 2017 Mar;20(3):496-506. (PMID: 28292496)
      Prev Sci. 2015 May;16(4):487-507. (PMID: 25744536)
    • Grant Information:
      0000 AOK Baden-Württemberg (DE)
    • Contributed Indexing:
      Keywords: Cost-effectiveness; Health promotion; Implementation research; Mental health; Prevention
    • Publication Date:
      Date Created: 20191019 Date Completed: 20191217 Latest Revision: 20200108
    • Publication Date:
      20240105
    • Accession Number:
      PMC6798355
    • Accession Number:
      10.1186/s12889-019-7585-4
    • Accession Number:
      31623597